Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENWL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,605
Award facts
- Contract value 100% obligated
- $56,604.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $56,604.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on October 21, 2025, is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V is a $30.3 billion acquisition strategy designed to ensure reliable pharmaceutical supply chains across Department of Defense healthcare facilities worldwide. This particular delivery order required no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group supplies a comprehensive portfolio of pharmaceutical products and medical consumables, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and over-the-counter drugs to support military healthcare operations. The company's parent IDC under PPV-G GEN V, awarded November 13, 2025, carries a $500 million ceiling with a completion date of December 31, 2036, structured as a 30-month base period with three optional 30-month extension periods. The company has demonstrated substantial performance capability through numerous delivery orders issued by the Defense Logistics Agency between October and November 2025, positioning it as a critical regional pharmaceutical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FENWL?
SPE2DU26FENWL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DU26FENWL worth?
The government has obligated $56,605 on SPE2DU26FENWL.
Is contract SPE2DU26FENWL an order under another contract?
Yes. SPE2DU26FENWL is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENWL competed?
The extent of competition for SPE2DU26FENWL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award